These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 23624828

  • 1. Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer.
    Li ZH, Zhang XB, Han XQ, Feng CR, Wang FS, Wang PG, Shen J, Shi YK.
    Oncol Rep; 2013 Jul; 30(1):499-505. PubMed ID: 23624828
    [Abstract] [Full Text] [Related]

  • 2. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
    Patra N, De U, Kim TH, Lee YJ, Ahn MY, Kim ND, Yoon JH, Choi WS, Moon HR, Lee BM, Kim HS.
    Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
    [Abstract] [Full Text] [Related]

  • 3. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
    Yang H, Xu W, Li Y, Lan P, Zhang J, Zhang Y, Zhang C.
    Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
    [Abstract] [Full Text] [Related]

  • 4. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
    Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P.
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997
    [Abstract] [Full Text] [Related]

  • 5. Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivo.
    Park KC, Kim SW, Park JH, Song EH, Yang JW, Chung HJ, Jung HJ, Suh JS, Kwon HJ, Choi SH.
    Cancer Sci; 2011 Feb; 102(2):343-50. PubMed ID: 21159061
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [Abstract] [Full Text] [Related]

  • 7. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
    Yang L, Liang Q, Shen K, Ma L, An N, Deng W, Fei Z, Liu J.
    Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
    Gravina GL, Marampon F, Giusti I, Carosa E, Di Sante S, Ricevuto E, Dolo V, Tombolini V, Jannini EA, Festuccia C.
    Int J Oncol; 2012 Mar; 40(3):711-20. PubMed ID: 22134754
    [Abstract] [Full Text] [Related]

  • 9. Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo.
    Hrzenjak A, Moinfar F, Kremser ML, Strohmeier B, Petru E, Zatloukal K, Denk H.
    Mol Cancer; 2010 Mar 04; 9():49. PubMed ID: 20202195
    [Abstract] [Full Text] [Related]

  • 10. Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.
    Zhang Y, Feng J, Jia Y, Wang X, Zhang L, Liu C, Fang H, Xu W.
    J Med Chem; 2011 Apr 28; 54(8):2823-38. PubMed ID: 21476600
    [Abstract] [Full Text] [Related]

  • 11. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC, Huang HH, Lai CY, Lin YJ, Liou JP, Lai MJ, Li YH, Teng CM, Yang CR.
    Oncotarget; 2016 Jan 05; 7(1):402-17. PubMed ID: 26587975
    [Abstract] [Full Text] [Related]

  • 12. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D, Ong JM, Hu J, Desmond JC, Kawamata N, Konda BM, Black KL, Koeffler HP.
    Clin Cancer Res; 2007 Feb 01; 13(3):1045-52. PubMed ID: 17289901
    [Abstract] [Full Text] [Related]

  • 13. Potent in vivo anti-breast cancer activity of IN-2001, a novel inhibitor of histone deacetylase, in MMTV/c-Neu mice.
    Joung KE, Min KN, An JY, Kim DK, Kong G, Sheen YY.
    Cancer Res; 2006 May 15; 66(10):5394-402. PubMed ID: 16707467
    [Abstract] [Full Text] [Related]

  • 14. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA.
    Urol Oncol; 2013 Nov 15; 31(8):1770-9. PubMed ID: 22944197
    [Abstract] [Full Text] [Related]

  • 15. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
    You BR, Han BR, Park WH.
    Oncotarget; 2017 Mar 14; 8(11):17726-17737. PubMed ID: 28099148
    [Abstract] [Full Text] [Related]

  • 16. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS.
    Int J Mol Med; 2008 Nov 14; 22(5):605-11. PubMed ID: 18949380
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor.
    Kim DH, Lee J, Kim KN, Kim HJ, Jeung HC, Chung HC, Kwon HJ.
    Biochem Biophys Res Commun; 2007 Apr 27; 356(1):233-8. PubMed ID: 17353008
    [Abstract] [Full Text] [Related]

  • 18. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
    Zuo X, Qin Y, Zhang X, Ning Q, Shao S, Luo M, Yuan N, Huang S, Zhao X.
    Oncol Rep; 2014 May 27; 31(5):2358-64. PubMed ID: 24676336
    [Abstract] [Full Text] [Related]

  • 19. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
    Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM.
    Cancer Res; 2004 Dec 01; 64(23):8778-81. PubMed ID: 15574791
    [Abstract] [Full Text] [Related]

  • 20. Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.
    Zhang Y, Fang H, Feng J, Jia Y, Wang X, Xu W.
    J Med Chem; 2011 Aug 11; 54(15):5532-9. PubMed ID: 21714538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.